Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 9/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 5: Figure S5

Description: Differentially abundant taxa between the TB and TB + HRZ groups at 3months HR therapy.

Abundance in Group 1: decreased abundance in TB +HRZ group - 3months HR(W16)

NCBI	Quality Control	Links
Tyzzerella
Acetivibrio
Stomatobaculum
Butyricicoccus
Gordonibacter
Acidaminobacter
Guggenheimella
Anaerovorax
Asaccharobacter
Robinsoniella
Hespellia
Alkaliphilus
Sporobacter
Acetanaerobacterium
Pseudobutyrivibrio
Ruminococcus
Pediococcus
Peptococcus
Roseburia
Roseivirga
unclassified Dysgonomonas
Clostridium
Romboutsia
Turicibacter
Coprobacter

Revision editor(s): KateRasheed